RMTI (Rockwell Medical) FFO


RMTI Rockwell Medical Inc RMTI
32 GF Score
Price $0.67
GF Value $0.87
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Rockwell Medical FFO?

FFO (Funds from operations) only applies to REITs.

RMTI
32GF Score
Rockwell Medical Inc RMTI
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Rockwell Medical (RMTI) Overvalued in 2026?

Based on GuruFocus' analysis, Rockwell Medical stock appears to be undervalued. The current stock price of $0.67 is trading 23.3% below its estimated GF Value™ of $0.87. GuruFocus considers Rockwell Medical to be Modestly Undervalued.

Key valuation signals for RMTI:

  • FFO:
  • GF Value™: $0.87 vs. price of $0.67 (23.3% below fair value)
  • GF Score™: 32/100 with 3 warning signs

No single metric tells the full story. See the RMTI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rockwell Medical Business Description

Other Exchanges RWMA:Germany
Address 30142 South Wixom Road, Wixom, MI, USA, 48393
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
32GF Score

Get the complete analysis for RMTI

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.67
Price
$0.87
GF Value